Skip to content

Computer Automated Detection (CAD) programme in identifying the presence of diabetic retinopathy (DR) and diabetic macular edema (DME) in persons with diabetes

A Study to assess the effectiveness of a Computer Automated Detection (CAD) programme in identifying the presence of diabetic retinopathy (DR) and diabetic macular edema (DME) in persons with diabetes - CAD-DR

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010588
Enrollment
1000
Registered
2017-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes Health Condition 2: null- Diabetes Mellitus

Interventions

None listed

Sponsors

Google Inc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: An eligible patient must:(1) have a diagnosis of diabetes mellitus; (2) have no history of any other retinal vascular disease, glaucoma, or other disease that may affect the appearance of the retina or optic disc (refractive error and ocular surface disease are allowed); (3) other than cataract surgery, have no history of intraocular surgery, ocular laser treatments for any retinal disease, or ocular injections for diabetic macular edema or proliferative disease; (4) have no media opacity precluding good retinal photography; and (5) be of age 40 or older.

Exclusion criteria

Exclusion criteria: Non-diabetic patients and other than the above said eligibility criteria

Design outcomes

Primary

MeasureTime frame
The sensitivity and specificity of the software in detecting referable diabetic retinopathy and diabetic macula edema (moderate or worse DR and referable DME) as compared to trained human graders.Timepoint: 4-6 months

Secondary

MeasureTime frame
The sensitivity and specificity of the software in detecting severe or worse diabetic retinopathy and referable diabetic macula edema as compared to trained human graders.Timepoint: 4-6 months

Countries

India

Contacts

Public ContactDr Varun Gulshan

Google Inc.

varungulshan@google.com919818043473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026